Redhill Biophrma ADR (RDHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,131 | -19,619 | -8,596 | -29,370 | -21,020 |
| Depreciation Amortization | 58 | 32 | 14 | 44 | 32 |
| Accounts receivable | -1,300 | -679 | 99 | 99 | N/A |
| Accounts payable and accrued liabilities | 7,675 | 5,204 | -39 | -60 | -94 |
| Other Working Capital | 4,956 | 2,381 | -583 | 553 | 2,116 |
| Other Operating Activity | -6,862 | -7,368 | -1,217 | 476 | 878 |
| Operating Cash Flow | $-30,604 | $-20,049 | $-10,322 | $-28,258 | $-18,088 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -22,907 | -29,213 | -18,997 | 24,592 | 3,212 |
| PPE Investments | -143 | -102 | N/A | -85 | -55 |
| Sale Of Investment | 14,532 | 5,847 | 400 | N/A | N/A |
| Purchase Sale Intangibles | -1,035 | N/A | N/A | -35 | N/A |
| Other Investing Activity | -1,035 | 0 | 0 | -35 | 0 |
| Investing Cash Flow | $-9,553 | $-23,468 | $-18,597 | $24,472 | $3,157 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,719 | 4,689 | 4,514 | 36,017 | 110 |
| Financing Cash Flow | $4,719 | $4,689 | $4,514 | $36,017 | $110 |
| Exchange Rate Effect | 315 | 361 | 242 | 39 | 77 |
| Beginning Cash Position | 53,786 | 53,786 | 53,786 | 21,516 | 21,516 |
| End Cash Position | 18,663 | 15,319 | 29,623 | 53,786 | 6,772 |
| Net Cash Flow | $-35,123 | $-38,467 | $-24,163 | $32,270 | $-14,744 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,604 | -20,049 | -10,322 | -28,258 | -18,088 |
| Capital Expenditure | -143 | -102 | N/A | -85 | -55 |
| Free Cash Flow | -30,747 | -20,151 | -10,322 | -28,343 | -18,143 |